Tirzepatide consent form or PDF checklist — what the process actually looks like

The myth: there's a PDF to sign before starting tirzepatide

A question our prescribers hear most weeks is some version of: "Where do I find the consent form to sign?" It's a completely reasonable thing to ask, consent forms are normal in surgery, clinical trials and certain procedures. The assumption is understandable.

For tirzepatide prescribed in a clinical setting, though, consent is not a signature on a file. It is the consultation itself. Your prescriber gathers your medical history, discusses why you want to lose weight, checks for contraindications, explains the realistic risks and realistic benefits, and confirms you have the information you need to make a free and informed decision. That exchange (written or verbal, structured or conversational) is the consent process under UK clinical and legal frameworks. The General Medical Council and Royal Pharmaceutical Society both frame informed consent as an ongoing dialogue, not a one-time document.

What does exist in written form is the Patient Information Leaflet on the eMC, which accompanies every pen and covers contraindications, side effects, storage, missed doses and the full dosing schedule. That leaflet is the document you should read carefully before using tirzepatide for the first time.

If a seller offers you tirzepatide along with a PDF form as the entirety of their process (no clinical conversation, no medical history check) that is a red flag, not a reassurance.

What a thorough prescriber reviews before approving tirzepatide

Informed consent for tirzepatide covers several distinct areas, all of which an Independent Prescriber should address before the first pen is dispatched. Understanding them helps you know what to expect during a genuine consultation.

Eligibility and BMI. Tirzepatide is licensed for adults with a BMI of 30 or above, or 27 and above with at least one weight-related condition such as high blood pressure, high cholesterol, prediabetes or obstructive sleep apnoea. Lower thresholds apply for some ethnic backgrounds under UK guidance. You can read more about who tirzepatide is designed for on the tirzepatide overview page.

Medical history and contraindications. Certain conditions (including a personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia type 2, or a previous episode of pancreatitis) require careful prescriber assessment. The NHS medicines page for tirzepatide lists the key cautions clearly.

Realistic expectations. In the SURMOUNT-1 trial, participants using the highest doses saw an average body-weight reduction of around 20 to 21 percent over 72 weeks, alongside a reduced-calorie diet and increased activity. That context (what the medicine can support, not guarantee) forms part of what a prescriber should explain.

Side effects you should know about before starting. Nausea, loose stools, constipation and indigestion are common at the start or after a dose step-up and usually settle within a few days. The prescriber should tell you this before you pick up your first pen, not after you experience it.

Contraception and other medicines. Women taking the oral contraceptive pill should add a non-oral method for the first four weeks of treatment and for four weeks after each dose increase, because tirzepatide's effect on gastric emptying can reduce pill absorption. Patients who are curious about whether tirzepatide comes in a pill form will find a full breakdown of what that means in practice on the dedicated page.

How online prescribing handles consent, and why the method matters

Online prescribing is legal and well-regulated in the UK, but it requires the same standard of clinical consent as an in-person consultation. At nume, the process follows the same principles: a structured health questionnaire covering your weight history, medical background, current medicines and any relevant conditions; photo-ID and live video weight verification; and a same-day review by a named GPhC-registered Independent Prescriber. A real clinician reads your answers, not automated software, not a tiered approval queue.

If the prescriber needs more information, they ask for it. If treatment is not clinically appropriate, it is declined. That outcome, too, is part of a proper consent process, the ability to say no is what gives a yes its meaning.

Thinking about what this involves financially? Treatment pricing and what is included in a single transparent price are set out on the weight-loss treatments page.

Anyone wanting to understand the full picture of Mounjaro as a medicine (how it works, storage, the dosing journey) will find that covered on the Mounjaro page. The clinical team profile sets out who reviews prescriptions at nume. General questions not answered here are usually covered in the FAQs.

What to do if you're preparing for a tirzepatide consultation

You do not need to locate a form or prepare paperwork. The most useful things to have ready are practical: your current weight (you'll confirm it on video), a note of any regular medicines including supplements, and an honest picture of any existing health conditions.

Read the Patient Information Leaflet when it arrives with your pen, that is the written document that governs your treatment. If anything in it raises a question, our team is reachable seven days a week. And if you are wondering whether you can get tirzepatide in pill form, the full guide to tirzepatide in pill form explains what is and is not currently available in the UK.

When you are ready to begin, check your eligibility and start the free consultation. The prescriber takes it from there.